Deadline: 29 January 2024
Applications are now open for the LifeX Accelerator program for early stage ventures commercializing a technology in digital health, medical devices, or therapeutics.
The Program
- Specialized Content
- Specifically tailored for early-stage healthcare and life science spin outs
- Intentional focus on preparing an investable commercialization plan
- Hands On Support
- Dedicated mentor with company specific expertise as a guide through the program
- Dedicated intern providing project support
- 1 on 1 office hours support with experts
- Access to a Broad & Diverse Network
- Program speakers and contributors include 40+ experts across multiple institutions, geographies, and industries
- Promotion of participating companies to LifeX’s broader network
Outcomes
- Funding: Follow on funding through SBIRs, PHDA, and other private investment
- Acceptance: Acceptance into subsequent accelerator programs including AlphaLab Health, IndieBio, Creative Destruction Labs
- Partnerships: Continued partnerships with regulatory, reimbursement, data privacy, & strategy services introduced through LifeX
- Talent Acquisition: Talent acquisition of team members introduced through Accelerator programming
Participant Profile
- Committed to commercializing a technology in the pharma, medical device, diagnostic or digital health space
- Have a proof of concept or validated the underlying scientific feasibility
- On the path to securing or licensing the necessary IP rights to commercialize
- Preferentially have already completed some basic business programming and customer discovery
- Have a founder committed to joining the company in an operational capacity in the future
- Program does not require a legal business entity be formed, but anticipate so in the near future
- At least one member of the founding team is able to spend a minimum of 6-8 hours per week participating in programming and dedicated work efforts for the duration of the accelerator program.
For more information, visit LifeX.
